Evaluation of Efficacy of Neoadjuvant Immunochemotherapy for Cervical Metastatic Squamous Cell Carcinoma of Unknown Primary
Neoadjuvant immunochemotherapy showed favorable efficacies, anticipated outcomes, and tolerable toxicity for patients with CMSCCUP. More clinical practice and clinical studies are still needed to confirm further.
Authors
- Mingyuan Du (ORCID: https://orcid.org/0000-0001-7432-521X)
- Wenmei Jiang
- Shu-Wei Chen (ORCID: https://orcid.org/0000-0003-4287-8607)
- Jiadong Liang (ORCID: https://orcid.org/0000-0001-9796-3767)
- Shuwen Fu
- Quan Zhang (ORCID: https://orcid.org/0000-0003-2660-2790)
- Xianlu Gao
- Ruiyu Li (ORCID: https://orcid.org/0000-0003-2074-4923)
- Shida Yan (ORCID: https://orcid.org/0000-0001-8777-3847)
- Chulin Yang
- Shiyan Yang (ORCID: https://orcid.org/0000-0002-5783-0561)
Institutions
- Sun Yat-sen University (CN)
- Chinese Academy of Sciences (CN)
- Zhejiang Cancer Hospital (CN)
- Stomatology Hospital (CN)
- Sun Yat-sen University Cancer Center (CN)
- Guangdong Provincial Center for Disease Control and Prevention (CN)
- Hospital of Stomatology, Sun Yat-sen University
- State Key Laboratory of Oncology in South China
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1002/cam4.70869
- Citations
- 1
- Primary Topic
- Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province